China

New Business

Policy body urges China to confront economic challenges, confident of demand recovery

China’s top economic policy coordinator has urged the country to confront unavoidable challenges, while expressing confidence that investment and consumption…

Read More »
New Business

China Vanke unveils fresh proposal to extend US$366 million bond after 3 failed bids

Distressed mainland developer China Vanke has unveiled a revised bond extension proposal, seeking approval from creditors after its initial three…

Read More »
New Business

Developing | Health and beauty chain Mannings to withdraw from mainland China

Mannings, one of Hong Kong’s largest health and beauty chains, will cease all retail operations in mainland China, both online…

Read More »
New Business

HashKey’s lukewarm debut tests Hong Kong’s ambitions as digital asset hub

Shares of HashKey Holdings, operator of Hong Kong’s largest licensed cryptocurrency exchange, were flat on their trading debut, as investors…

Read More »
New Business

China’s new drug insurance: lifeline for patients or squeeze on big pharmaceutical firms?

Mainland China’s 17 million Alzheimer’s patients can, for the first time, pay less out of pocket for a costly drug…

Read More »
New Business

Surviving the shocks: what China and the US learned from 2025’s trade war

It has been a turbulent year for the fraught US-China relationship. In the second story in this new series, we…

Read More »
New Business

Why South Korea is becoming China’s new bargain travel hotspot amid Japan spat

As Chinese tourists pull back from visiting Japan amid a diplomatic row, a slumping won is positioning South Korea as…

Read More »
New Business

China slaps anti-dumping duties on EU pork, but lowers final rates

China has announced anti-dumping taxes of up to 19.8 per cent on pork imports from the European Union, following an…

Read More »
New Business

Opinion | Global finance is quietly moving east

The opening of the International Monetary Fund’s (IMF) Shanghai Centre on December 8 attracted limited attention outside specialist financial circles.…

Read More »
New Business

Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion

A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a…

Read More »
Back to top button